pancrelipase

It is used to treat exocrine pancreatic insufficiency (reduced pancreatic function) caused by cystic fibrosis, chronic pancreatitis, surgery to the pancreas or stomach, or by tumors obstructing the ducts. It may also be useful for pancreatic insufficiency in the elderly.

Form: capsules, modified release, hard

ATC: A09AA02

Manufacturer: VIATRIS ITALIA S.R.L.

It is used to treat exocrine pancreatic insufficiency, a condition in which the pancreas does not produce enough enzymes to digest food. It is indicated for people with cystic fibrosis, chronic pancreatitis, pancreatic cancer, or for those who have undergone partial or total removal of the pancreas.

Form: capsules, hard gelatin, gastro-resistant

ATC: A09AA02

Manufacturer: Viatris Healthcare Limited